Download HERV encoded envelope proteins – key players in autoimmunity?

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Polyclonal B cell response wikipedia , lookup

Anti-nuclear antibody wikipedia , lookup

Vaccination wikipedia , lookup

Allergy wikipedia , lookup

Immunomics wikipedia , lookup

Periodontal disease wikipedia , lookup

Rheumatic fever wikipedia , lookup

Pathophysiology of multiple sclerosis wikipedia , lookup

Ankylosing spondylitis wikipedia , lookup

Neglected tropical diseases wikipedia , lookup

Neuromyelitis optica wikipedia , lookup

Globalization and disease wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Myasthenia gravis wikipedia , lookup

Germ theory of disease wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Inflammation wikipedia , lookup

Rheumatoid arthritis wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Molecular mimicry wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Autoimmunity wikipedia , lookup

Transcript
HERV encoded envelope proteins –
key players in autoimmunity?
Emmer A, Kornhuber ME
Dept.
of
Neurology,
Martin-Luther
University, Halle (Saale), Germany
The pathogenesis of most autoimmune
diseases is as yet unknown. Human
endogenous retroviruses (HERV) have been
discussed to play a role in autoimmune
diseases of most body organs such as e.g.
brain, skin, joints, muscles, bowel,
endocrine glands, kidney and blood vessels. The key feature of autoimmune diseases is
inflammation. When autoimmunity would be driven by HERVs, the according
inflammation needs to be explained. HERV-encoded envelope proteins (env) can
presumably act as strong immune stimulators (superantigens). Previously, we have
demonstrated that T-cell superantigens such as Staphylococcal enterotoxin A (SEA) are
capable to induce a cellular inflammatory reaction in different organs such as CNS,
joints and muscles of experimental animals. The character of the inflammation induced
by the same superantigen (SEA) differed from organ to organ and showed similarities
with the respective autoimmune diseases known for each of the investigated organs.
Induction of inflammation by the superantigen did not require adjuvant-crackup of
immune tolerance, which is a necessary requirement in so-called autoimmune disease
models that use conventional antigens. Beside cellular inflammatory features, many
autoimmune diseases show humoral autoimmune characteristics such as oligoclonal
immunoglobulin bands in multiple sclerosis cerebrospinal fluid or different types of
blood serum autoantibodies in other autoimmune diseases. Previously, we have shown
that B-cell superantigens such as gp120, i.e. part of the HIV-envelope, are capable to
activate blood leucocytes in vitro to produce immunoglobulin in an oligoclonal manner.
Antigen specificities present among these immunoglobulins were e.g. Measles, Rubella,
Herpes-Zoster. When a superantigenic stimulus is taken into consideration, the diverse
autoantibody specificities present in many autoimmune diseases becomes easy to
understand.
Another feature of autoimmune diseases is organ degeneration. Usually organ
degeneration is attributed to inflammation alone. However, degeneration may develop
almost or completely without inflammation such as e.g. in primary progressive multiple
sclerosis. When the dualism of HERV and HERV-superantigen driven inflammation is
taken into consideration, it becomes readily understandable that HERV effects may
exist by themselves, i.e. without inflammation. Thus, a HERV pathogenesis is better
compatible with known features of autoimmune diseases than the so-called
autoimmune models with conventional antigens.